Skip to main content

Barton Ford Haynes

Frederic M. Hanes Distinguished Professor of Medicine
Medicine, Duke Human Vaccine Institute
DUMC Box 103020, Durham, NC 27710
106 Research Drive, Msrbii 4090, Durham, NC 27710

Awards & Honors


Fellow (NAI)

Other National Academy of Inventors · 2015 More about this award

Highly Cited Researcher

National Thomson Reuters · 2014

AAI-Steinman Award for Human Immunology Research

National American Association of Immunologists · 2013

Alexander Fleming Award

National Infectious Disease Society of America · October 2011

Alexander Fleming Award

National Infectious Diseases Society of America · 2011

Fellows

National American Academy of Arts and Sciences · 2007 Area: Biological Sciences; Specialty: Medical Sciences More about this award

Highly Cited Researcher

National Thomson Reuters · 2001

Distinguished Investigator Award

National American College of Rheumatology · October 2000

Member

National Institute of Medicine of The National Academies · 1997

Member

Scholarly Society National Academy of Medicine · 1997 More about this award

Lee Howley, Sr. Prize in Basic Research

National The Arthritis Foundation · 1995

In the News


Published December 9, 2024
A Vaccine Strategy to Guide an Immune System Response to HIV
Published June 6, 2024
At Duke, Fauci Reflects on a Remarkable Career
Published May 20, 2024
Trial HIV Vaccine Triggered Elusive and Essential Antibodies in Humans
Published December 18, 2023
Leadership Comes Naturally to Kevin Saunders
Published November 16, 2023
Which Duke Scholars Made the Most Cited List?
Published March 15, 2023
Gift Honors 30-Year Collaboration of Renowned Vaccine Researchers
Published January 31, 2023
Duke Human Vaccine Institute Wins Contract to Produce Pan-Coronavirus Vaccine
Published October 28, 2022
New Pan-Coronavirus Vaccine Passes Key Experiments, Demonstrates Protection
Published October 13, 2022
Federal Grant to School of Medicine Expands HIV Research
Published September 13, 2022
Duke Study Finds Key Component of Potential HIV Vaccine Is Effective in Primates
Published September 13, 2022
Duke Study Finds Key Component of Potential HIV Vaccine Is Effective in Primates
Published March 16, 2022
Study Shows mRNA Vaccine Technology Can Be Used For HIV Vaccines
Published November 2, 2021
Duke, UNC-Chapel Hill Scientists Identify New Antibody For COVID-19 and Variants
Published October 21, 2021
Duke Researchers Receive Federal Grant to Roll Out Next-Generation Coronavirus Vaccine
Published May 20, 2021
Newly Identified Antibody Can Be Targeted by HIV Vaccines
Published May 14, 2021
Fauci Singles Out Possible Coronavirus Vaccine from Duke
Published May 10, 2021
New Vaccine Blocks COVID-19 and Variants, Plus Other Coronaviruses
Published December 16, 2020
Barton Haynes Answers the Essential Questions About the COVID Vaccine
Published November 6, 2020
Years in the Making: Duke Human Vaccine Institute Researchers Attack COVID-19
Published September 14, 2020
How Close Are We to a COVID-19 Vaccine?
Published August 20, 2020
Duke Institute Tapped to Test Preventive Antibodies for COVID-19
Published July 22, 2020
Duke to Start Trial of Promising COVID Antibody Treatment
Published March 27, 2020
Duke Researchers Pivot to Attack the New Coronavirus
Published March 2, 2020
The Quest for an AIDS Vaccine
Published January 31, 2020
Creating a Vaccine to Guide the Immune System to Make the Right Kind of Antibodies
Published November 19, 2019
Global List of Highly Cited Puts Duke in Top Ten
Published September 30, 2019
Duke Vaccine Institute Plays Integral Role in National Effort to Improve Flu Shots
Published July 10, 2019
Duke Institute Awarded $129 Million Grant in Ongoing Quest for HIV Vaccine
Published November 27, 2018
Duke Faculty Plentiful On ‘Highly Cited’ List
Published September 27, 2018
Researchers Find How Natural Killer Cells Regulate Protective HIV Antibodies
Published October 16, 2017
Duke Institute Tapped to Build a Rapid-Response System for Viral Pandemics
Published June 9, 2017
Investigational Vaccine Protected Monkeys from HIV-Like Virus
Published March 21, 2017
Researchers Map Pathways to Protective Antibodies for an HIV Vaccine
Published March 21, 2017
DGHI Professor and Penn Colleagues Develop Zika Candidate Vaccine
Published August 3, 2016
Tracking How HIV Disrupts Immune System Informs Vaccine Development
Published May 3, 2016
Researchers Find Alternative Pathways to HIV Antibodies
Published March 11, 2016
The rare super-antibodies that destroy HIV
Published March 4, 2016
Researchers Unravel Pathways of Potent Antibodies that Fight HIV Infection
Published December 11, 2015
Lefkowitz, Haynes Elected Fellows of Inventors Academy
Published October 2, 2015
DART Protein Shows Potential as Shock-and-Kill Strategy Against HIV
Published January 15, 2015
Human Mode Of Responding To HIV Vaccine Is Conserved From Monkeys
Published August 14, 2014
Gut Flora Influences HIV Immune Response
Published July 26, 2014
Mechanism Found for Development of Protective HIV Antibodies
Published March 12, 2014
Rare double infection: Lupus patient makes antibodies to fight HIV
Published January 13, 2014
Tricky Protein May Help HIV Vaccine Development